Cargando…
Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition
BACKGROUND: Pulmonary fibrosis is a late manifestation of acute respiratory distress syndrome (ARDS). Sepsis is a major cause of ARDS, and its pathogenesis includes endotoxin-induced vascular injury. Recently, endothelial-to-mesenchymal transition (EndMT) was shown to play an important role in pulmo...
Autores principales: | Suzuki, Toshio, Tada, Yuji, Gladson, Santhi, Nishimura, Rintaro, Shimomura, Iwao, Karasawa, Satoshi, Tatsumi, Koichiro, West, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644255/ https://www.ncbi.nlm.nih.gov/pubmed/29037205 http://dx.doi.org/10.1186/s12931-017-0660-4 |
Ejemplares similares
-
Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document
por: Suzuki, Toshio, et al.
Publicado: (2015) -
Selective targeting of KRAS-driven lung tumorigenesis via unresolved ER stress
por: Shimomura, Iwao, et al.
Publicado: (2021) -
Choroidal Metastasis of Non-Small Cell Lung Cancer That Responded to Gefitinib
por: Shimomura, Iwao, et al.
Publicado: (2013) -
Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018) -
LCZ696 ameliorates lipopolysaccharide-induced endothelial injury
por: Gao, Aihong, et al.
Publicado: (2021)